PROGRESSIS EMULSION FOR INJECTION FOR PIGS (SOWS AND GILTS)

Šalis: Airija

kalba: anglų

Šaltinis: HPRA (Health Products Regulatory Authority)

Veiklioji medžiaga:

INACTIVATED PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) VIRUS, P120 STRAIN

Prieinama:

Merial Animal Health Limited

ATC kodas:

QI09AA05

INN (Tarptautinis Pavadinimas):

INACTIVATED PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) VIRUS, P120 STRAIN

Vaisto forma:

Emulsion for Injection

Recepto tipas:

POM: Prescription Only Medicine as defined in relevant national legislation

Farmakoterapinė grupė:

Porcine

Gydymo sritis:

porcine reproductive and respiratory syndrome (PRRS) virus

Terapinės indikacijos:

Immunological - Inactivated vaccine

Autorizacija statusas:

Authorised

Leidimo data:

2003-06-06

Prekės savybės

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Progressis
Emulsion for injection for pigs (sows and gilts)
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 2-ml dose of vaccine contains:
ACTIVE SUBSTANCE:
Inactivated Porcine Reproductive and Respiratory Syndrome (PRRS)
virus,
P120 strain
................................................................................................
2.5 log 10 IF* units.
*IF units: ImmunoFluorescence antibody titre obtained after 2
injections in pigs under specific laboratory conditions.
ADJUVANT:
O/w oily excipient (containing hydrogenated polyisobutene as adjuvant)
.... q.s. 1 dose of 2 ml.
EXCIPIENT(S):
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Emulsion for Injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs (sows and gilts).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Reduction of the reproductive disorders caused by Porcine Reproductive
and Respiratory Syndrome virus (European
strain) in a contaminated environment:
vaccination reduces the number of early farrowings and the number of
still-
births.
4.3 CONTRAINDICATIONS
None.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
In PRRS infected herds, viral infection is heterogeneous and varies
over time. In such context, the implementation of a
vaccination program is a tool to improve the reproductive parameters
and may contribute to the disease control in
conjunction with sanitary measures.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_